Spruce Biosciences Files 8-K on Delisting and Exit Costs
Ticker: SPRB · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1683553
| Field | Detail |
|---|---|
| Company | Spruce Biosciences, Inc. (SPRB) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, restructuring, financial-distress
Related Tickers: SPRB
TL;DR
SPRB 8-K: Delisting warning & exit costs filed. Big trouble brewing.
AI Summary
Spruce Biosciences, Inc. filed an 8-K on April 25, 2025, reporting on cost-associated exit or disposal activities, and a notice of delisting or failure to meet continued listing rules. The filing indicates potential financial distress or restructuring for the company, which is based in South San Francisco, California.
Why It Matters
This filing signals significant operational or financial challenges for Spruce Biosciences, potentially impacting its stock value and future viability.
Risk Assessment
Risk Level: high — The filing explicitly mentions a notice of delisting or failure to meet continued listing rules, indicating severe financial or operational issues.
Key Players & Entities
- Spruce Biosciences, Inc. (company) — Registrant
- April 21, 2025 (date) — Earliest event reported
- April 25, 2025 (date) — Date of report
- South San Francisco, California (location) — Company headquarters
- 001-39594 (other) — Commission File Number
FAQ
What specific reasons led to the notice of delisting or failure to meet continued listing rules?
The filing does not specify the exact reasons for the delisting notice, but it is filed under 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing'.
What are the 'Cost Associated with Exit or Disposal Activities' mentioned in the filing?
The filing indicates that 'Cost Associated with Exit or Disposal Activities' is an item being reported, but the specific details and financial impact of these costs are not elaborated in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 21, 2025.
What is the primary business of Spruce Biosciences, Inc. according to the filing?
According to the filing, Spruce Biosciences, Inc. falls under the Standard Industrial Classification of 'PHARMACEUTICAL PREPARATIONS [2834]'.
What is the company's principal executive office address?
The company's principal executive office is located at 611 Gateway Boulevard, Suite 740, South San Francisco, California, 94080.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding SPRUCE BIOSCIENCES, INC. (SPRB).